These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6521853)

  • 1. Limited involvement of central noradrenergic pathways in morphine-induced antinociception.
    Berge OG; Ogren SO
    Neuropharmacology; 1984 Oct; 23(10):1179-85. PubMed ID: 6521853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal DSP4 selectively depletes spinal noradrenaline and attenuates morphine analgesia.
    Zhong FX; Ji XQ; Tsou K
    Eur J Pharmacol; 1985 Oct; 116(3):327-30. PubMed ID: 2866969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separate involvement of the spinal noradrenergic and serotonergic systems in morphine analgesia: the differences in mechanical and thermal algesic tests.
    Kuraishi Y; Harada Y; Aratani S; Satoh M; Takagi H
    Brain Res; 1983 Aug; 273(2):245-52. PubMed ID: 6616237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the noradrenaline neurotoxin DSP4 on the postnatal development of central noradrenaline neurons in the rat.
    Jonsson G; Hallman H; Sundström E
    Neuroscience; 1982; 7(11):2895-907. PubMed ID: 7155358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological modifications of the neurotoxic action of the noradrenaline neurotoxin DSP4 on central noradrenaline neurons.
    Hallman H; Jonsson G
    Eur J Pharmacol; 1984 Aug; 103(3-4):269-78. PubMed ID: 6237924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 6-hydroxydopamine-induced lesions to ascending and descending noradrenergic pathways on morphine analgesia.
    Sawynok J; Reid A
    Brain Res; 1987 Sep; 419(1-2):156-65. PubMed ID: 3119144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete blockade and attenuation of 5-hydroxytryptamine induced analgesia following NA depletion in rats and mice.
    Archer T; Arweström E; Jonsson G; Minor BG; Post C
    Acta Pharmacol Toxicol (Copenh); 1985 Oct; 57(4):255-61. PubMed ID: 3841256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the analgesic effect of morphine on models of acute nociceptive pain in rats with a central noradrenergic system lesion.
    Roczniak W; Oswiecimska JM; Brodziak-Dopierala B; Cipora E; Nowak PG; Babuska-Roczniak M
    Neuro Endocrinol Lett; 2016 Jul; 37(3):239-244. PubMed ID: 27618597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a selective brain noradrenergic involvement in the locomotor stimulant effects of amphetamine in the rat.
    Ogren SO; Archer T; Johansson C
    Neurosci Lett; 1983 Dec; 43(2-3):327-31. PubMed ID: 6687006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test-specific effects of the 5-HT reuptake inhibitors alaproclate and zimelidine on pain sensitivity and morphine analgesia.
    Ogren SO; Holm AC
    J Neural Transm; 1980; 47(4):253-71. PubMed ID: 6446594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of central noradrenergic system lesion on the serotoninergic 5-HT3 receptor mediated analgesia in rats.
    Roczniak W; Wróbel J; Dolczak L; Nowak P
    Adv Clin Exp Med; 2013; 22(5):629-38. PubMed ID: 24285447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central noradrenergic activity affects analgesic effect of Neuropeptide S.
    Jinushi K; Kushikata T; Kudo T; Calo G; Guerrini R; Hirota K
    J Anesth; 2018 Feb; 32(1):48-53. PubMed ID: 29128909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid-monoamine interactions in spinal antinociception: evidence for serotonin but not norepinephrine reciprocity.
    Kellstein DE; Malseed RT; Goldstein FJ
    Pain; 1988 Jul; 34(1):85-92. PubMed ID: 2841636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal administration of thiorphan, bestatin, desipramine and fluoxetine differentially potentiate the antinociceptive effects induced by beta-endorphin and morphine, administered intracerebroventricularly.
    Suh HH; Tseng LL
    Neuropharmacology; 1990 Mar; 29(3):207-14. PubMed ID: 2139187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desipramine potentiates spinal antinociception by 5-hydroxytryptamine, morphine and adenosine.
    Sawynok J; Reid A
    Pain; 1992 Jul; 50(1):113-118. PubMed ID: 1513600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of morphine-induced analgesia by p-chlorophenylalanine and p-chloroamphetamine: test-dependent effects and evidence for brainstem 5-hydroxytryptamine involvement.
    Berge OG; Hole K; Ogren SO
    Brain Res; 1983 Jul; 271(1):51-64. PubMed ID: 6224533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of norepinephrine in forebrain and brainstem seizures: chemical lesioning of locus ceruleus with DSP4.
    Mishra PK; Burger RL; Bettendorf AF; Browning RA; Jobe PC
    Exp Neurol; 1994 Jan; 125(1):58-64. PubMed ID: 8307124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of ciprofloxacin and gentamicin on spinal morphine-induced antinociception in rats.
    Luger TJ; Farkas W; Geisler H; Lorenz IH
    Basic Clin Pharmacol Toxicol; 2005 May; 96(5):366-74. PubMed ID: 15853929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat.
    Archer T; Fredriksson A; Jonsson G; Lewander T; Mohammed AK; Ross SB; Söderberg U
    Psychopharmacology (Berl); 1986; 88(2):141-6. PubMed ID: 3081924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locus coeruleus lesions in the rat enhance the antinociceptive potency of centrally administered clonidine but not morphine.
    Ossipov MH; Chatterjee TK; Gebhart GF
    Brain Res; 1985 Aug; 341(2):320-30. PubMed ID: 4041798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.